Medical devices, healthcare technology and the business of care
510(k) clearance · K260758

MAGNETOM Free.Max; MAGNETOM Free.Star

Siemens Shenzhen Magnetic Resonance , Ltd. · Decision date Sep 1, 2026

FDA DECISIONK260758

What did the FDA decide?

FDA records K260758 as a 510(k) premarket notification, with a decision dated Sep 1, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 1, 2026

FDA source record

Regulatory record facts

Identifier
K260758
Regulatory pathway
510(k) premarket notification
Product code
LNH
Decision code
SESE
Decision date
Sep 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Nuclear Magnetic Resonance Imaging.

Product code
LNH
FDA device class
2

FDA decision timeline

  1. K260758 received

    Application receipt date recorded by FDA.

  2. K260758 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LNH

Product / regulatory recordCompanyPathwayDecision dateSource
Siemens Healthineers AG510(k) clearanceNov 5, 2026FDA
Fujifilm Corporation510(k) clearanceOct 9, 2026FDA
Vista AI, Inc.510(k) clearanceOct 7, 2026FDA
Airs Medical, Inc.510(k) clearanceOct 1, 2026FDA
Fujifilm Corporation510(k) clearanceSep 16, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Siemens Shenzhen Magnetic Resonance , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records